Tecan Freedom Evo NAP

在新冠肺炎暴发期间，MRCG的分子诊断实验室是冈比亚唯一有能力和有能力提供新冠肺炎实验室诊断服务的合格实验室。除了为MRCG临床服务部门提供实验室诊断服务外，冈比亚卫生部通过国家公共卫生实验室完全依靠我们的服务来支持该部的新冠肺炎疫情应对。满足控制暴发和支持新冠肺炎研究所需的更多检测的需要的一个主要瓶颈是进行黄金标准RT-PCR检测程序中的手动步骤。这意味着实验室必须动员和培训多达80名科学官员来处理全国各地收到的样本，以满足不到24小时的周转时间，这对住院管理至关重要。这种不间断的实验室服务对于临床服务部门有效管理患者和为单位出差提供检测服务至关重要。人工处理和操纵这种高度传染性的样本增加了实验室接触和污染的风险。随着实验室团队成员开始受到新冠肺炎的影响，实验室面临着提供中断的日常服务和24小时以下周转时间的严峻挑战。这些设备将用于支持新冠肺炎实验室诊断，以应对疫情爆发，但此外，它还将通过增强我们应对其他新出现的高度传染性疾病的能力，为全球卫生研究做出重大贡献。它还将增加我们实验室方法的价值，以支持更好地研究感染、传播和免疫的动态，并在培训和能力建设方面支持我们的西非战略伙伴。分子诊断实验室将使用它来支持临床服务部门和MRCG单位的所有其他研究项目。机构环境和支持设备将放置在分子诊断实验室的现有结构中。MRCG股的生物医学工程部将提供常规设备维护，并将纳入其设备维护计划。目前，类似的设备正在用于处理新冠肺炎诊断和研究项目样本的日常样本处理。此外，MRCG生物医学工程人员已经接受过类似设备的培训，对此类设备具有实用知识，并得到制造商的良好服务支持。来自主办机构、外部项目合作伙伴(S)或资助者的捐款该设备将由该单位的生物医学工程部进行维护。研究项目将有助于抵消维护费用。

During the COVID-19 outbreak, the Molecular diagnostic laboratory at the MRCG was the only competent laboratory in The Gambia with the capacity and capability to offer COVID-19 laboratory diagnostic services. In addition to providing laboratory diagnostic services for the MRCG clinical service department, the Ministry of Health of The Gambia through the National Public Health laboratories relied exclusively on our services to support the Ministry's COVID-19 outbreak response. A major bottleneck in meeting the need for increased testing required to contain the outbreak and support COVID-19 research is the manual steps in the procedure for conducting the gold standard RT-PCR test. This meant that the laboratories had to mobilise and train up to 80 scientific officers to process the samples received throughout the country to meet the turnaround time of less than 24 hours which was critical for in-patient management. This uninterrupted laboratory service was critical to the Clinical Services to effectively manage its patients and provide testing services for Unit travel. The manual handling and manipulation of such highly infectious samples increased the risk of laboratorian exposure and contamination. The laboratories faced serious challenges to offer an interrupted daily service with a turnaround time of under 24 hours as members of the laboratory team begin to be affected by COVID-19. The equipment will be used for supporting COVID-19 laboratory diagnostics in response to the outbreak but in addition, it will contribute significantly to Global Health Research by enhancing our capacity for other emerging highly infectious diseases. It will also add value to our laboratory methods to support better research in understanding the dynamics of infection, transmission, and immunity and support our West African strategic partners in both training and capacity building. It will be used by the Molecular diagnostic laboratories to support the clinical service department and also all other research projects in MRCG Unit.Institutional environment and support The equipment will be housed in the available structure in the Molecular Diagnostic laboratory. The Biomedical Engineering department at the MRCG Unit will provide routine equipment maintenance and will be included in their equipment maintenance plan. At the moment, similar equipment is being used for handling daily sample processing of COVID-19 diagnostic and research project samples. In addition, MRCG Biomedical Engineering staff are already trained on similar equipment and have a serviceable knowledge of this type of equipment, and receive good service support from the manufacturer.Contributions from host institutions, external project partner(s) or fundersThe equipment will be maintained by the Unit's Biomedical Engineering department. Research projects will contribute towards offsetting the cost of maintenance.